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Background: Protracted, multi-year wait times exist for bariatric care in Canada. Our objective was to examine
wait-listed patients’ health status and perceptions regarding the consequences of prolonged wait times using a
cross-sectional study design nested within a prospective cohort.
Methods: 150 consecutive consenting subjects wait-listed for multi-disciplinary bariatric assessment in a
population-based medical/surgical bariatric program were surveyed. Health status was measured using a visual
analogue scale (VAS). A Waiting List Impact Questionnaire (WLIQ) examined employment, physical stress, social
support, frustration, quality of life, and satisfaction with care. Multivariable linear regression analysis adjusted for age,
sex and BMI identified independent predictors of lower VAS scores.
Results: 136 (91%) subjects were women, mean age was 43 years (SD 9), mean BMI was 49.4 (SD 8.3) kg/m2
and average time wait-listed was 64 days (SD 76). The mean VAS score was 53/100 (SD 22). According to the
WLIQ, 47% of subjects agreed/strongly agreed that waiting affected their quality of life, 65% described wait
times as ‘concerning’ and 81% as ‘frustrating’. 86% reported worsening of physical symptoms over time.
Nevertheless, only 31% were dissatisfied/very dissatisfied with their overall medical care. Independent predictors
of lower VAS scores were higher BMI (beta coefficient 0.42; p = 0.03), unemployment (13.7; p = 0.01) and
depression (10.3; p = 0.003).
Conclusions: Patients wait-listed for bariatric care self-reported very impaired health status and other adverse
consequences, attributing these to protracted waits. These data may help benchmark the level of health
impairment in this population, understand the physical and mental toll of waiting, and assist with wait list
management.
Trial registration: Clinicaltrials.gov NCT00850356
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Morbid obesity (defined herein as a body mass index
[BMI] of ≥ 35 kg/m2) affects 8.9% of Canadians and has
tripled in prevalence from 1978-79 to 2007-09 [1,2]. Pre-
mature mortality, obesity-related comorbidity, dimin-
ished quality of life and higher health care costs are
more likely to afflict morbidly obese individuals com-
pared to their normal weight counterparts [3,4]. Man-
aging the complications and encouraging treatment of* Correspondence: rpadwal@ualberta.ca
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reproduction in any medium, provided the orobesity has become a major priority and a public health
concern.
Current clinical practice guidelines emphasize the
complex, chronic nature of obesity and stress the im-
portance of lifelong, sustainable lifestyle change [5,6].
They also identify a multidisciplinary approach to the
assessment and management of obese individuals as the
most effective and the preferred treatment approach
[5,6]. Medical therapy consists primarily of intensive
lifestyle modification (diet, exercise and behavioural
modification counselling) and is recommended for all
obese individuals, including those that are morbidly
obese [5,6]. Accordingly, broad multidisciplinary teamLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mental health is required to optimally deliver lifestyle
modification [6]. In addition, according to these guide-
lines, bariatric surgery should be considered in patients
refractory to non-surgical therapy who have either se-
vere obesity (BMI ≥40 kg/m2) or moderate obesity
(BMI 35.0-39.9 kg/m2) and a major obesity related
comorbidity (e.g., hypertension, sleep apnea, diabetes)
[6,7].
Weight management interventions are infrequently
delivered in the primary care setting, and providers cite
several reasons for this including a lack of training to
deliver weight management interventions, a lack of ac-
cess to multidisciplinary allied health team support and
a relative paucity of effective interventions [8]. Compre-
hensive multidisciplinary medical and surgical obesity
bariatric care within Canada’s publicly funded health
care system is thus usually delivered by multidisciplinary
bariatric specialty clinics. However, access to such care
is limited because of high demand, limited capacity,
lengthy wait lists and protracted, multiyear wait times
[9]. For example, estimated wait times for surgery in
Canada average 5 years [10] and wait times for the
medical and surgical bariatric care of morbidly obese
individuals within a regional program in Alberta,
Canada average 2-3 years [11]. In both Canada and Eng-
land, well under 1% of potentially eligible individuals
received bariatric surgery in 2009-10 [7,9,11]. UK baria-
tric surgeons have characterized access in their country
as ‘inconsistent, unethical and completely dependent
upon geographic location’ and some primary care trusts
within the UK appear to be limiting surgeries to
patients with BMI levels above 50 kg/m2 in an attempt
to ration the number of procedures performed and re-
duce wait list volumes [7,12,13]. In stark contrast to the
wait times experienced by bariatric patients, benchmark
wait times for other elective surgeries in Canada such
as orthopedic procedures, coronary bypass and cataract
removal are ≤16 weeks [14]. In 80% of cases, Canadians
are receiving these procedures within benchmark times
[14].
Medical and surgical treatments for obesity can reduce
weight and medical comorbidity and improve health-
related quality of life (QOL); improvements in these out-
comes are especially large following surgery [15-18].
Thus, lengthy wait times are widely considered by baria-
tric specialists to be detrimental to physical and mental
health [9]. However to our knowledge no prior study has
assessed patients’ perspectives on this matter, and data
examining health status and patients’ views regarding
the impact and consequences of waiting are nonexistent.
The purpose of this study was to assess these patient-
reported or humanistic outcomes in a representative




One hundred and fifty consecutive consenting adult (age
≥18 years) subjects wait-listed for assessment in the Ed-
monton Weight Wise Clinic were surveyed. Edmonton
Weight Wise is a regional obesity program established
2005 to deliver integrated, patient-focused, evidence-
based care to the Edmonton Zone of Alberta Health
Services (AHS) [11]. The Edmonton Zone is one of the
largest integrated health delivery regions in Canada,
serving a catchment population of approximately 1.6
million residents within greater Edmonton. Weight Wise
consists of a central, region-wide, single-point-of-access
referral system; community education and weight man-
agement sessions; and adult and pediatric bariatric spe-
cialty clinics. The adult specialty clinic provides both
medical and surgical treatment to practitioner-referred
patients 18 years of age or greater with BMI levels of
35 kg/m2 or greater who have been unsuccessful with
prior attempts at managing chronic obesity. Approxi-
mately 800 new referrals are seen and approximately 200
bariatric surgeries are performed annually. We estimate
that over 125 000 adult patients within the Weight Wise
catchment area have a BMI ≥ 35 kg/m2 [11].
After new referrals to the adult clinic are confirmed to
be complete and appropriate, patients then are desig-
nated as ‘wait-listed’ and wait in queue until they are
granted an initial clinic visit in the adult specialty clinic.
Subjects involved in the present study were recruited
shortly after they were wait-listed (within months) and
were waiting for their initial assessment in the adult spe-
cialty clinic (Figure 1). All patients entering the adult
clinic undergo a multidisciplinary obesity evaluation and
medical management program (e.g., intensive lifestyle
modification, mental health assessment, screening for
obstructive sleep apnea and eating disorders, physiother-
apy and social worker assessment if needed), typically
lasting 4-6 months. Patients interested in surgery also
undergo a multidisciplinary assessment during this
period to determine if they are appropriate for this pro-
cedure and, if approved for surgery, typically undergo the
procedure after 3-6 months of additional wait. Patients
not interested in surgery continue received intensive
medical management for an additional six months. At
the time this study was conducted, the time from referral
processing to the initial clinic visit averaged over two
years and over 1500 patients were wait listed.
Study cohort
The 150 subjects included in the present analysis com-
prise the wait-list arm of the Alberta Population-based
Figure 1 Structure of the Edmonton Weight Wise Program..
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and Economic Impact of Bariatric Surgery (APPLES)
study. Details with respect to this study, including tech-
nical appendices, have been previously published [11]. In
summary, APPLES is a 500-patient, population-based,
two-year prospective controlled study designed to assess
the impact of extended wait-times for bariatric care and
examine the clinical and cost-effectiveness of bariatric
treatment in the Canadian context. In APPLES, 150 bar-
iatric surgery subjects, 200 medical subjects and 150
wait-listed subjects were enrolled in consecutive fashion
between January 2009-February 2010. At the time of
interview and data collection, wait-listed subjects were
facing wait times of approximately 2-3 years before their
initial assessment in the adult clinic.
Outcomes are reported in the entire 150-patient wait-
listed sample and in the subgroup of subjects indicating
a ‘strong’ or ‘very strong’ interest in undergoing bariatric
surgery (n = 96) to facilitate generalizability to programs
in which patients are wait-listed for both surgical and
medical bariatric care, as well as primarily surgical
treatment.
The University of Alberta Research Ethics Board
approved this study and informed consent was obtained
from all subjects.
Data collection and measurements
Subjects were asked to rate their overall state of health
from 0-100 using a visual analogue scale (VAS) with 100
reflecting the ‘best imaginable state of health’ [19]. Satis-
faction with medical care was assessed in a similar man-
ner to other studies conducted in this health region
[20,21] using two previously validated items taken from
the Patient Satisfaction Questionnaire [22], which werescored on a 5-point Likert Scale and both positively and
negatively worded to reduce acquiescent response bias:
a. The medical care I have been receiving is just about
perfect
b. I am dissatisfied with some things about the medical
care I received.
The Waiting List Impact Questionnaire (WLIQ) [23],
adapted from a study of wait times for coronary revascu-
larization was administered to assess the perceived im-
pact of protracted wait times on health status. The
WLIQ originally consisted of a series of 47 statements
identified through an open-ended patient interview
process, each scored using a 5-point Likert scale, that
examined the impact of waiting on 5 domains (employ-
ment, physical stress, social support, frustration and
quality of life). Seven cardiac surgery-specific items
deemed not relevant to the bariatric setting were elimi-
nated [23]. One statement that assessed the subject’s de-
gree of interest in bariatric surgery was incorporated in
with the remaining 39 items constituted the 40-item
WLIQ used herein; the modified WLIQ questionnaire
has been previously published in its entirety [11].
We collected basic sociodemographic information and
clinical data at the time of program intake (i.e., soon
after they were wait-listed). Subjects with a history of
hypertension, blood pressure levels of greater than 140/
90 mm Hg at the baseline visit [11], or subjects receiving
antihypertensive drug treatment were considered hyper-
tensive. Patients with a history of type 2 diabetes, on
treatment with antidiabetic medications or who had a
single fasting glucose measurement of 7.0 mmol/L or
greater were classified with diabetes. Depression was









Mean age (years) 43 (9) 44 (9)
Female Sex 136 (91) 89 (93)
Weight (kg) 134.7 (25.1) 135.5 (24.7)
Body Mass Index (kg/m2) 49.4 (8.3) 49.9 (8.4)
Time on Wait List (days) 64 (76) 59 (74)
Smoking
Never 62 (41) 34 (35)
Former 64 (43) 41 (43)
Current 24 (16) 21 (22)
Marital Status
Married/Common Law 80 (53) 46 (48)
Divorced/Separated 22 (15) 18 (19)
Single 48 (32) 32 (33)
Education
No high school 1 (1) 0 (0)
Some high school 16 (11) 8 (8)
High school diploma 26 (17) 16 (17)
Some post-secondary 27 (18) 13 (14)
Post-secondary graduate 80 (53) 59 (62)
Annual Income
Less than $15 000 9 (6) 6 (6)
$15 000 – 29 999 17 (11) 9 (9)
$30 000 – 49 999 22 (15) 16 (17)
$50 000 – 79 999 45 (30) 27 (28)
$80 000 or greater 52 (35) 33 (34)
Not answered 5 (3) 5 (5)
Employment Status
Full-time 90 (60) 59 (62)
Part-time 18 (12) 12 (13)
Casual/volunteer 1 (1) 1 (1)
Long-term disability 12 (8) 9 (9)
Homemaker 9 (6) 5 (5)
Unemployed 15 (10) 8 (8)
Retired 5 (3) 4 (4)
Other 5 (3) 3 (3)
Race
Caucasian 138 (92) 90 (94)
Hispanic 1 (1) 1 (1)
First Nations 2 (1) 2 (2)
South Asian 2 (1) 2 (2)
Other 6 (4) 1 (1)
Type 2 Diabetes 35 (23) 22 (23)
Hypertension 70 (47) 45 (47)
Dyslipidemia 38 (25) 27 (28)
Table 1 Baseline Demographics (Continued)
Coronary Artery Disease 6 (4) 6 (6)
Peripheral Vascular Disease 2 (1) 0 (0)
Cerebrovascular Disease 1 (1) 1 (1)
Congestive Heart Failure 0 (0) 0 (0)
Sleep Apnea 44 (29) 32 (33)
On CPAP 19 (13) 13 (14)
Gastroesophageal Reflux 57 (38) 44 (46)
Osteoarthritis 44 (29) 31 (32)
Polycystic Ovarian Syndrome 20 (13) 16 (17)
Hypothyroidism 32 (21) 25 (26)
Depression 93 (62) 68 (71)
Fibromyalgia 18 (12) 15 (16)
Anxiety 69 (46) 48 (50)
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ment with antidepressant medications. The presence of
all other comorbidities was determined by self-report.Analysis
Descriptive analyses, consisting of means, medians, and
proportions were conducted. For ease of presentation,
responses to the WLIQ and patient satisfaction items
were collapsed from five categories into three – strongly
agree/agree, neutral and disagree/strongly disagree.
Multivariable linear regression was used to identify
independent predictors of health status according to
the VAS in all 150 subjects. Age, sex, and BMI (per unit
increase) were first forced into all models. Additional
covariates with a p-value < 0.20 on univariate analysis
were also considered in the initial model. Potential
model covariates included all the variables listed in
Table 1. The final model was created using a stepwise
backwards selection method to determine which of
these additional covariates contributed to the model at
a Wald Chi-square p-value of 0.2. SAS (Version 9.2,
Cary, NC) and SPSS (PSW 18, Somers, NY) were used
for all analyses.Results
Baseline characteristics
The pre-defined sample size of 150 was reached after
425 subjects had been telephoned (overall response rate
35%). The 275 subjects that did not participate had
demographic characteristics similar to the respondents.
240 (89%) were female, with a mean age of 42.9 (SD 9.3)
years and a mean BMI of 47.2 kg/m2 (SD 7.1).
Baseline sociodemographic characteristics of the parti-
cipants are detailed in Table 1. The mean number of days
on the wait list at the time of survey was 64 (SD 76).
Table 2 Linear Regression Analysis Examining Predictors of the Visual Analogue Scale (n = 150)*
Predictor Variable Beta-coefficient P value Beta-coefficient P value
(Univariable) (Multivariable)
Age (years) -0.08 0.68 0.11 0.52
Female sex 13.4 0.03 8.34 0.16
Body mass index (kg/m2) -0.57 0.008 -0.42 0.03
Time on Waitlist (days) -0.01 0.32
Smoker (former or current) 10.3 0.03
Married or common law (vs. all other categories) -2.9 0.42
Post-secondary graduate (vs. all other education levels) 4.7 0.24
Low income, ≤$30, 000 (vs. all other income categories) -3.45 0.47
Employed full or part-time (vs. all other categories) 17.7 <0.0001 13.7 0.0003
Type 2 diabetes -3.6 0.34
Hypertension -5.3 0.17
Dyslipidemia -2.7 0.51
Coronary artery disease -6.4 0.48
Sleep apnea -12.9 0.0009 -6.55 0.095
Gastroesophageal reflux -7.2 0.05
Osteoarthritis -9.4 0.02
Polycystic ovarian syndrome 1.78 0.74
Hypothyroidism -0.37 0.93
Depression -12.18 0.0009 -10.28 0.003
Fibromyalgia -8.73 0.12
Anxiety -6.54 0.07
*Predictor variables with p values < 0.2 were candidates for final model. Age, BMI and sex are forced in final model, which was constructed using a backward
selection procedure.
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The average overall state of health score according to
the VAS was 53/100 (SD 22) in the overall sample and
49/100 (SD 22) in the subgroup interested in bariatric
surgery. In the final multivariable analyses, the inde-
pendent correlates of lower VAS scores were higher
body mass index (beta coefficient 0.42; p = 0.03), un-
employment (13.7; p = 0.01), and depression (10.3;
p = 0.003) (Table 2). Sleep apnea was of borderline sig-
nificance (6.6; p = 0.09). Overall model R [2] was 0.20.
Waiting list impact questionnaire
Responses to all 40 items are summarized in Table 3 and
responses according to each domain are outlined below.
Quality of life
The majority of subjects expressed concern over wait
times (65%) and felt that waiting was very stressful (53%)
and physically, emotionally and mentally taxing (62%).
Employment
A minority of subjects indicated that they were unable
to work (14%) or unable to work a full shift (17%). How-
ever, 46% of subjects still indicated that money was an
issue in their lives.Physical stress
Physical limitations were common, with 85% reporting
reduced activity, 83% reporting activity limitations com-
pared to previous activity levels and 69% reporting wor-
sening physical limitations over time.
Social support
The majority of subjects reported a supportive social
network (82%), faith in their physicians (76%) and trying
to cope with waiting (91%). 74% indicated interest in
attending a support group or classes to learn more about
obesity.
Frustration
Of the respondents, 81% of subjects indicated that the
wait for care was frustrating, 73% worried about the
consequences of extended wait times on their health,
68% were frustrated with the allocation of resources and
59% felt that they should not have to wait for obesity
treatment.
Satisfaction
Of the 150 subjects surveyed, 59% strongly agreed/
agreed that the medical care they had received was ‘just
about perfect’, 23% were uncertain, 16% disagreed/
Table 3 Waiting List Impact Questionnaire Results
Statement No. of Patients With Response (%)
All patients (n = 150) Subgroup Interested in Surgery (n = 96)
SA/A N D/SD SA/A N D/SD
Quality of Life
I have no control over the situation 46(30) 21(14) 83(55) 36(38) 12(13) 48(50)
I just want to get it over with 79(53) 31(21) 40(27) 63(66) 12(13) 21(22)
Waiting has affected my quality of life 71(47) 34(25) 42(28) 56(58) 20(21) 20(21)
The length of waiting is a big concern 98(65) 28(19) 24(16) 73(76) 11(12) 12(13)
It is very stressful waiting for obesity treatment 79(53) 31(21) 40(27) 66(69) 14(15) 16(17)
My life has been put on hold while I wait for obesity treatment 43(29) 32(21) 75(50) 35(37) 17(18) 44(46)
Waiting costs you physically, mentally and financially 93(62) 30(20) 27(18) 68(71) 16(17) 12(13)
I am anxious and worried about treatment 67(45) 25(17) 57(38) 48(51) 14(15) 33(35)
There is no quality of life while waiting for treatment 32(22) 33(22) 84(56) 25(26) 20(21) 50(53)
Employment Issues
Because of my weight problem, I am unable to work 21(14) 17(11) 112(75) 15(16) 11(12) 70(73)
Because of my weight problem, I can’t work a full shift 26(17) 12(8) 112(75) 20(21) 9(9) 67(70)
Money is a great issue for me now 68(46) 31(21) 50 (34) 45(47) 22(23) 29(30)
Physical Stress
I make sure I don’t overdo things 96(64) 9(6) 45(30) 60(63) 6(6) 30(31)
Physical activities take me longer now 124(83) 8(5) 18(12) 87(91) 2(2) 7(7)
My activity is reduced because of my obesity 126(85) 11(7) 12(8) 91(96) 1(1) 3(3)
I can’t do many of the things I used to do 120(81) 12(8) 17(11) 87(92) 4(4) 4(4)
I am very short of breath 84(56) 17(11) 48(32) 65(68) 11(12) 19(20)
I have angina 7(5) 45(31) 95(65) 6(7) 36(39) 51(55)
The rest of my body is suffering because of my weight condition 129(86) 8(5) 13(9) 89(93) 4(4) 3(3)
My symptoms are getting worse 103(69) 23(15) 24(16) 75(78) 14(15) 7(7)
I am feeling fine now 52(35) 23(15) 75(50) 27(28) 13(14) 56(58)
I’m not sure what activity I can do without hurting my condition 60(41) 34(23) 55(37) 42(43) 24(25) 30(31)
I’ve stopped smoking recently 17(12) 55(37) 75(51) 13(14) 29(31) 53(56)
Social Support
My family and friends are very patient and supportive 123(82) 15(10) 12(8) 79(82) 8(8) 9(9)
I try to cope 137(91) 10(7) 3(2) 94(98) 2(2) 0(0)
I have faith in the doctors 115(76) 19(13) 16(11) 73(76) 11(12) 12(13)
Waiting is very tough on my family and friends 68(45) 53(35) 29(19) 50(52) 28(29) 18(19)
I would attend a support group for people with obesity 111(74) 24(16) 15(10) 75(78) 14(15) 7(7)
A big factor is the lack of communication in the system 74(49) 55(37) 21(14) 50(52) 34(35) 12(13)
I would attend a class to learn more about obesity 121(81) 16(11) 13(9) 80(83) 8(8) 8(8)
Frustration
It frustrates me that I have to wait for obesity treatment 121(81) 14(9) 15(10) 87(91) 3(3) 6(6)
I worry about what might happen while waiting (e.g. worsening
symptoms, heart attack, death)
110(73) 19(13) 21(14) 85(89) 5(5) 6(6)
I’m frustrated with the allocation of resources 101(68) 32(22) 16(11) 71(75) 17(18) 7(7)
The problem with the waiting list is the allocation of resources 92(62) 42(28) 15(10) 66(70) 23(24) 6(6)
I am mad and upset about the wait 60(40) 52(35) 38(25) 49(51) 30(31) 17(18)
I am scared of treatment for obesity 57(38) 32(21) 60(41) 37(39) 20(21) 39(41)
I am afraid to go away from the phone for too long in case I miss a call
for obesity treatment
12(8) 49(33) 89(59) 10(10) 34(35) 52(54)
The waiting list is not fair to everybody 64(43) 49(33) 36(24) 52(55) 29(31) 14(15)
I shouldn’t have to wait for obesity treatment 88(59) 33(22) 29(19) 65(68) 15(16) 16(17)
SA/A = strongly agree/agree; N = neutral; D = disagree/strongly disagree.
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percent of subjects were ‘dissatisfied with some things
about the medical care they received’, 17% were uncer-
tain, 49% disagreed/strongly disagreed, and 3% did not
answer.
Subgroup interested in bariatric surgery
Results were broadly similar in this subgroup, although
greater impairments in the quality of life, frustration and
physical stress domains of the WLIQ were apparent
compared to the overall sample (Table 3). Patient satis-
faction results were nearly identical to the overall sample
(data not shown).
Discussion
Most patients wait-listed for multidisciplinary bariatric
assessment within a population-based regional bariatric
program attributed impairments in overall health status
and adverse health consequences to their time spent
waiting. In particular, overall VAS scores were very low
and the WLIQ scores indicated that the domains of
quality of life, frustration, and physical stress were most
affected, particularly in subjects interested in surgery.
Nevertheless, the majority of patients were still satisfied
with their medical care.
The number of patients who meet guideline-
concordant eligibility for surgery is currently orders of
magnitude greater than the capacity to perform this pro-
cedure and will likely rise further if contemporary trends
in the prevalence of morbidly obesity continue [24,25].
Thus, only a fraction of eligible patients will realistically
ever undergo a bariatric procedure. In 2009, an esti-
mated 1.5 million Canadian adults were potentially eli-
gible for bariatric surgery, yet only 1500 publically
funded bariatric procedures (0.1% of eligible patients)
were performed [11]. Applying similar calculations [9] to
2009-10 obesity prevalence figures from England, we es-
timate 3.3 million individuals were potentially eligible
for bariatric surgery and yet only 3600 surgeries were
performed (also equal to 0.1% of eligible patients) [7]. A
recent economic analysis from England reported that
expanding the provision of surgery from the current
capacity to 5% of eligible patients would save £417 mil-
lion over three years, with savings largely realized from
increased productivity, reduced health care costs and
reduced disability payments [7]. Yet, a survey of 23 Pri-
mary Care Trusts in England found that only 5 (23%)
were planning to increase provision of surgery and 4
(17%) were planning to decrease the number of proce-
dures performed [7]. In Canada, national surgical
volumes from 2004-07 have remained flat, and although
several provinces have recently announced plans to in-
crease provision of surgery, others have either cut back
or have decided against offering bariatric procedures totheir populace [26]. These data suggest that large
increases in the numbers of bariatric surgery performed
within the public health care sector are unlikely to occur
in the near future.
The strikingly low VAS scores found in this sample in-
dicate a substantial degree of self-reported health status
impairment. The mean value of 49 is markedly lower
than the average score of 85 previously reported in a
random sample of community-dwelling adults drawn
from the same population as our study sample [27]. In
fact, the mean VAS scores in our bariatric population
are considerably lower than those reported other chronic
medical conditions (Figure 2) such as diabetes and
COPD with VAS scores of 66 and 65 respectively
[23,28,29].
To our knowledge, this is the first study to examine
perceptions of the impact of extended wait times on
health, patient satisfaction and VAS scores in wait-listed
patients. We found only one other study examining
QOL in severely obese patients wait-listed for bariatric
care [30]. This Norwegian study reported that both the
mental and physical components of the Short Form-12
(SF-12) were markedly lower in 128 severely obese
patients compared to population norms. However, wait
time duration, patients’ views regarding wait times and
patient satisfaction were not assessed. Our findings are
also similar to previous studies reporting lower quality
of life compared to population controls in patients
approved for and awaiting bariatric surgery and other
elective procedures such as coronary bypass grafting and
joint replacement [18,23,31,32]. However, unlike patients
already approved for bariatric or other types of surgery,
the patients we studied interested in surgery were still
facing protracted multiyear wait times before even being
assessed for this procedure. Given the association be-
tween poor self-reported health status and increased
morbidity and mortality [32] and given that health status
and quality of life improve after medical and surgical
bariatric care [15-18], our results raise concern regarding
the potentially detrimental (and previously under-
appreciated) health ramifications of extended wait times
for bariatric care.
It is also noteworthy that we identified higher BMI
levels, unemployment and depression as statistically sig-
nificant independent correlates of lower VAS scores. Be-
yond statistical significance, the magnitude of difference
in health status between employed and unemployed
individuals (12 points on the VAS) and depressed and
non-depressed subjects (10 points) are clinically import-
ant [33]. These results suggest that support programs to
help maintain workforce participation for bariatric
patients may be of value – even while they await assess-
ment and more definitive bariatric management. In
addition, because protracted wait times are unlikely to
Figure 2 Comparison of Visual Analogue Scores (VAS) in Different Patient Samples. Error Bars depict standard deviations. VAS scores for
non-bariatric samples taken from references 20 and 22. CAD = coronary artery disease; COPD = emphysema.
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tems, supportive interventions designed to treat depres-
sion and reduce the physical and psychological stress of
waiting may improve health status and quality of life in
wait-listed patients. Such interventions are ideally best
delivered as an adjunct to ongoing non-surgical weight
management efforts, although there are as yet no rando-
mized trial data to support this contention. That said, a
small randomised trial evaluating a nurse led, shared
care monthly intervention consisting of health education
and motivational interviews for wait-listed coronary ar-
tery bypass surgery candidates significantly improved
cardiovascular risk factors as well as general health sta-
tus, levels of depression, anxiety, and physical activity
levels compared to usual care [34]. Similarly, improve-
ments in quality of life, well-being and social support
were reported in a telephone-based psychosocial inter-
vention for patients awaiting lung transplantation [35].
Studies evaluating similar interventions in bariatric
populations should be considered, although because of
the large number of individuals wait-listed, group inter-
ventions would likely be required.
Strengths and limitations
The main strengths of this work are that the sample was
population-based, that the data were collected prospect-
ively, and that it is the first investigation of its kind
among patients wait listed for multidisciplinary bariatric
assessment and management. We feel that the results of
our study can be readily generalizable to other programs
across Canada given the population-based nature of our
data and the similarities between bariatric care delivery(especially for surgery) in other Canadian provinces.
There are however several limitations. First, the cross-
sectional design of our study limits our ability to meas-
ure changes in health status and satisfaction over time,
but ongoing follow-up of the APPLES cohort will pro-
vide longitudinal data on these and additional outcomes
[11]. Second, our population was surveyed early during
their wait (within a few months of a multi-year process)
and we cannot yet determine if health status and quality
of life will further deteriorate or start to improve over
time. Third, the survey participation rate was low at
35%, which limits the generalizability of the results to all
wait-listed patients. However, we do note that there were
no major differences in the demographic characteristics
of those who participated and those who did not. Fourth,
the sample was comprised primarily of women, limiting
the generalizability of the results to males. However, the
demographics (including the female sex preponderance
and relatively high education and income levels) of our
study sample are similar to nationally representative
samples of patients undergoing bariatric care [36,37].
Fifth, although the WLIQ has been previously used in
patients with coronary disease, there are no studies ex-
plicitly validating this instrument in morbidly obese
patients.
Conclusions
In conclusion, we have identified that patients wait listed
for bariatric surgery report very impaired health status
and that depression, unemployment and higher BMI
predict greater health status impairment. Care providers
and decision makers should consider the heretofore
Padwal et al. BMC Health Services Research 2012, 12:139 Page 9 of 10
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(and the ramifications with respect to quality and quan-
tity of life) when devising strategies to optimally manage
wait lists within publicly funded bariatric programs.
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